These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29191624)

  • 1. Phosphate Kinetic Models in Hemodialysis: A Systematic Review.
    Laursen SH; Vestergaard P; Hejlesen OK
    Am J Kidney Dis; 2018 Jan; 71(1):75-90. PubMed ID: 29191624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling.
    Debowska M; Poleszczuk J; Wojcik-Zaluska A; Ksiazek A; Zaluska W
    Artif Organs; 2015 Dec; 39(12):1005-14. PubMed ID: 25994493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
    Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G
    J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
    Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in Hyperphosphatemia Using Phosphate Education and Planning Talks.
    Brauer A; Waheed S; Singh T; Maursetter L
    J Ren Nutr; 2019 Mar; 29(2):156-162. PubMed ID: 30087012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis.
    St-Jules DE; Rozga MR; Handu D; Carrero JJ
    Clin J Am Soc Nephrol; 2020 Dec; 16(1):107-120. PubMed ID: 33380474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.
    Wald R; Rabbat CG; Girard L; Garg AX; Tennankore K; Tyrwhitt J; Smyth A; Rathe-Skafel A; Gao P; Mazzetti A; Bosch J; Yan AT; Parfrey P; Manns BJ; Walsh M
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):965-973. PubMed ID: 28550080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate Binders and Targets Over Decades: Do We have it Right Now?
    Marcuccilli M; Chonchol M; Jovanovich A
    Semin Dial; 2017 Mar; 30(2):134-141. PubMed ID: 28064444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.
    Slinin Y; Greer N; Ishani A; MacDonald R; Olson C; Rutks I; Wilt TJ
    Am J Kidney Dis; 2015 Nov; 66(5):823-36. PubMed ID: 26498415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.
    Chan MW; Cheah HM; Mohd Padzil MB
    Int J Clin Pharm; 2019 Oct; 41(5):1282-1289. PubMed ID: 31302884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian parameter estimation for phosphate dynamics during hemodialysis.
    Bangsgaard KO; Andersen M; Heaf JG; Ottesen JT
    Math Biosci Eng; 2023 Jan; 20(3):4455-4492. PubMed ID: 36896508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution volume assessment compartment modelling: theoretic phosphate kinetics in steady state hemodialys patients.
    Laursen SH; Buus A; Jensen MH; Vestergaard P; Hejlesen OK
    Int J Artif Organs; 2015 Nov; 38(11):580-7. PubMed ID: 26659481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphatemia and its relationship with blood pressure, vasoconstriction, and endothelial cell dysfunction in hypertensive hemodialysis patients.
    Jung J; Jeon-Slaughter H; Nguyen H; Patel J; Sambandam KK; Shastri S; Van Buren PN
    BMC Nephrol; 2022 Aug; 23(1):291. PubMed ID: 35999520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
    Leypoldt JK
    Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
    Kuhlmann MK
    Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation.
    Spalding EM; Chamney PW; Farrington K
    Kidney Int; 2002 Feb; 61(2):655-67. PubMed ID: 11849409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN; Lewis JB; Dwyer JP; Greene T; Middleton J; Sika M; Umanath K; Abraham JD; Arfeen SS; Bowline IG; Chernin G; Fadem SZ; Goral S; Koury M; Sinsakul MV; Weiner DE;
    Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate removal and hemodialysis conditions.
    Pohlmeier R; Vienken J
    Kidney Int Suppl; 2001 Feb; 78():S190-4. PubMed ID: 11169009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
    Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ
    Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.